Bloomberg BusinessweekBloomberg Businessweek

Inovio Pharmaceuticals CEO on Vaccine Development

View descriptionShare
 

Dr. J. Joseph Kim, CEO at Inovio Pharmaceuticals, discusses vaccine development for COVID-19. Kim points out that there's been "a lot of incremental successes" in phase one trials. He also talks about the importance of ensuring safety and efficacy.

Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Businessweek

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and  
Social links
Follow podcast
Recent clips
Browse 5,415 clip(s)